Search for: "SANDOZ, INC." Results 381 - 400 of 679
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
5 May 2010, 4:46 am
SmithKline Beecham plc & Anor v Sandoz AG & Anor (Afro-IP) Cenestin (conjugated estrogens)– US: Patent infringement suit in response to Para IV challenge: Teva Women's Health, Inc. v. [read post]
18 Nov 2009, 4:57 am
Sandoz Inc (Patent Docs) Roundup Ready soybean seed - US: Monsanto files patent infringement suit based on defendant's use of seed produced from earlier planted Roundup Ready soybean seed: Monsanto Co. et al. v. [read post]
18 Nov 2009, 4:57 am
Sandoz Inc (Patent Docs) Roundup Ready soybean seed – US: Monsanto files patent infringement suit based on defendant’s use of seed produced from earlier planted Roundup Ready soybean seed: Monsanto Co. et al. v. [read post]
18 Nov 2009, 4:57 am
Sandoz Inc (Patent Docs) Roundup Ready soybean seed - US: Monsanto files patent infringement suit based on defendant's use of seed produced from earlier planted Roundup Ready soybean seed: Monsanto Co. et al. v. [read post]
31 Jan 2012, 6:13 am by Bexis
  Joe represents one of the successful moving defendants in the very recent decision that's described below.Take it away Joe:*****************On January 30, 2012, the United States District Court for the Eastern District of New York granted summary judgment in favor of Sandoz Inc., APP Pharmaceuticals, Inc., Ben Venue Laboratories, Inc., Teva Parenteral Medicines, Inc., and Hospira, Inc. with respect to all remaining plaintiffs in the… [read post]
16 Jan 2017, 5:44 pm by Dennis Crouch
Lexmark International, Inc., No. 15-1189 (unreasonable restraints on downstream uses) Briefing: Sandoz Inc. v. [read post]
18 Sep 2016, 6:03 pm by Dennis Crouch
Lexmark International, Inc., No. 15-1189 (unreasonable restraints on downstream uses) BPCIA – Notice of Commercial Marketing: Sandoz Inc. v. [read post]
31 Aug 2010, 10:01 pm by Kelly
Apotex Inc. et al (Docket Report) Lovenox (Enoxaparin) – US: DC District Court denies preliminary injunction in generic Lovenox case; Is the juice worth the squeeze for Sanofi to appeal? [read post]
1 Aug 2011, 8:19 am
The seven defendants, Actavis Elizabeth LLC, Sun Pharmaceuticals, Sandoz Inc., Mylan Pharmaceuticals, Apotex Inc., Aurobindo Pharma Ltd., and Teva Pharmaceuticals, had filed an Abbreviated New Drug Application (ANDA) seeking to utilize Lilly's patented formula and claiming invalidity of Lilly's patent, No. 5,658,590, Treatment of attention-deficit/hyperactivity disorder, which has been issued by the US Patent Office. [read post]
17 Feb 2018, 2:54 am
"The concerns noted by Lord Oliver in Reckitt & Colman Ltd v Borden Inc [1990] 1 All E.R. 873 have remained at the forefront of the judicial mind and whilst they have come in and out of vogue over the years, they are now accepted as a necessary evil in at least some circumstances.The survey question was recently considered in Glaxo Wellcome UK Ltd (t/a Allen & Hanburys) & Anor v Sandoz Ltd & Ors [2017] EWHC 3196 (Ch). [read post]
16 Feb 2015, 1:21 pm by Lawrence B. Ebert
Council, Inc.,467 U.S. 837, 842 (1984); accord Cooper, 536 F.3d at 1337(quoting Hawkins v. [read post]